Oligomers SIGNED
Characterising protein oligomers and their role in neurodegenerative disease in humans
Total Cost €
0EC-Contrib. €
0Partnership
0Views
0Oligomers project word cloud
Explore the words cloud of the Oligomers project. It provides you a very rough idea of what is the project "Oligomers" about.
Project "Oligomers" data sheet
The following table provides information about the project.
| Coordinator |
THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE
Organization address contact info |
| Coordinator Country | United Kingdom [UK] |
| Total cost | 2˙499˙551 € |
| EC max contribution | 2˙499˙551 € (100%) |
| Programme |
1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC)) |
| Code Call | ERC-2014-ADG |
| Funding Scheme | ERC-ADG |
| Starting year | 2015 |
| Duration (year-month-day) | from 2015-09-01 to 2021-08-31 |
Partnership
Take a look of project's partnership.
| # | ||||
|---|---|---|---|---|
| 1 | THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE | UK (CAMBRIDGE) | coordinator | 2˙499˙551.00 |
Map
Project objective
Small soluble protein aggregates play a key role in the onset and spreading of Alzheimer’s and Parkinson’s diseases. However, which oligomers are present in human disease and which are toxic remains unknown because ultrasensitive methods do not exist to detect and characterise the low concentration of oligomers, which are highly heterogeneous in size and structure. To address this problem we will develop fluorescence based methods to detect and characterise individual oligomers to measure the oligomer size, structure, proteinase K resistance, seeding capability and composition. We will also develop methods to enrich these oligomers so we can use mass spectrometry to determine post translational modifications and recover the oligomers to directly test their cytotoxicity and mechanism of damage. The capability to characterise these oligomers at this unprecedented level of detail will represent a major advance in the field. These methods will then be applied to stem cell models of Alzheimer’s disease and Parkinson’s disease and then clinical samples of CSF from patients. These experiments will determine how the number, composition or structure of the oligomers changes in the disease and if this results in increased cytotoxicity. Clinical samples of CSF from patients with genetic mutations will be used to determine if detectable changes in the oligomers occur early in the disease and samples of brain tissue used to determine the changes in oligomers during the spreading of the disease.
By the end of the project we will have determined which oligomers play major roles in the onset and spreading of Alzheimer’s and Parkinson’s disease in humans, providing targets for therapies, and tested if the detection and characterisation of these oligomers can be used for early diagnosis of the disease.
Publications
| year | authors and title | journal | last update |
|---|---|---|---|
| 2019 |
Suman De, David C. Wirthensohn, Patrick Flagmeier, Craig Hughes, Francesco A. Aprile, Francesco S. Ruggeri, Daniel R. Whiten, Derya Emin, Zengjie Xia, Juan A. Varela, Pietro Sormanni, Franziska Kundel, Tuomas P. J. Knowles, Christopher M. Dobson, Clare Bryant, Michele Vendruscolo, David Klenerman Different soluble aggregates of Aβ42 can give rise to cellular toxicity through different mechanisms published pages: , ISSN: 2041-1723, DOI: 10.1038/s41467-019-09477-3 |
Nature Communications 10/1 | 2020-03-23 |
| 2020 |
Craig Hughes, Minee L. Choi, Jee-Hyun Yi, Seung-Chan Kim, Anna Drews, Peter St. George-Hyslop, Clare Bryant, Sonia Gandhi, Kwangwook Cho, David Klenerman Beta amyloid aggregates induce sensitised TLR4 signalling causing long-term potentiation deficit and rat neuronal cell death published pages: , ISSN: 2399-3642, DOI: 10.1038/s42003-020-0792-9 |
Communications Biology 3/1 | 2020-03-23 |
| 2019 |
Suman De, Daniel R. Whiten, Francesco S. Ruggeri, Craig Hughes, Margarida Rodrigues, Dimitrios I. Sideris, Christopher G. Taylor, Francesco A. Aprile, Serge Muyldermans, Tuomas P. J. Knowles, Michele Vendruscolo, Clare Bryant, Kaj Blennow, Ingmar Skoog, Silke Kern, Henrik Zetterberg, David Klenerman Soluble aggregates present in cerebrospinal fluid change in size and mechanism of toxicity during Alzheimer’s disease progression published pages: , ISSN: 2051-5960, DOI: 10.1186/s40478-019-0777-4 |
Acta Neuropathologica Communications 7/1 | 2020-03-23 |
| 2019 |
Craig D. Hughes, Minee L. Choi, Mina Ryten, Lee Hopkins, Anna Drews, Juan A. BotÃa, Maria Iljina, Margarida Rodrigues, Sarah A. Gagliano, Sonia Gandhi, Clare Bryant, David Klenerman Picomolar concentrations of oligomeric alpha-synuclein sensitizes TLR4 to play an initiating role in Parkinson’s disease pathogenesis published pages: 103-120, ISSN: 0001-6322, DOI: 10.1007/s00401-018-1907-y |
Acta Neuropathologica 137/1 | 2020-03-23 |
| 2018 |
Ji-Eun Lee, Jason C. Sang, Margarida Rodrigues, Alexander R. Carr, Mathew H. Horrocks, Suman De, Marie N. Bongiovanni, Patrick Flagmeier, Christopher M. Dobson, David J. Wales, Steven F. Lee, David Klenerman Mapping Surface Hydrophobicity of α-Synuclein Oligomers at the Nanoscale published pages: 7494-7501, ISSN: 1530-6984, DOI: 10.1021/acs.nanolett.8b02916 |
Nano Letters 18/12 | 2020-03-23 |
| 2018 |
Mathew Horrocks, Daniel R Whiten, Yukun Zuo, Laura Calo, Minee-Liane Choi, Suman De, Patrick Flagmeier, David C Wirthensohn, Franziska Kundel, Steven F Lee, Christopher Dobson, Sonia Gandhi, Maria Spillantini, David Klenerman, Rohan T Ranasinghe, Santiago E Sanchez, Dilan Athauda Nanoscopic characterization of individual endogenous protein aggregates in human neuronal cells published pages: , ISSN: 1439-4227, DOI: 10.1002/cbic.201800209 |
ChemBioChem | 2020-03-03 |
| 2018 |
Christopher G. Taylor, Georg Meisl, Mathew H. Horrocks, Henrik Zetterberg, Tuomas P. J. Knowles, David Klenerman Extrinsic Amyloid-Binding Dyes for Detection of Individual Protein Aggregates in Solution published pages: 10385-10393, ISSN: 0003-2700, DOI: 10.1021/acs.analchem.8b02226 |
Analytical Chemistry 90/17 | 2020-03-03 |
| 2018 |
Kundel, F.; Hong, L.; Falcon, B.; McEwan, W. A.; Michaels, T. C. T.; Meisl, G.; Esteras, N.; Abramov, A. Y.; Knowles, T. J. P.; Goedert, M.; Klenerman, D. Measurement of Tau Filament Fragmentation Provides Insights into Prion-like Spreading published pages: 1276–1282, ISSN: 1948-7193, DOI: 10.17863/CAM.25419 |
ACS Chemical Neuroscience (2018) | 2020-03-03 |
| 2018 |
Daniel R. Whiten, Dezerae Cox, Mathew H. Horrocks, Christopher G. Taylor, Suman De, Patrick Flagmeier, Laura Tosatto, Janet R. Kumita, Heath Ecroyd, Christopher M. Dobson, David Klenerman, Mark R. Wilson Single-Molecule Characterization of the Interactions between Extracellular Chaperones and Toxic α-Synuclein Oligomers published pages: 3492-3500, ISSN: 2211-1247, DOI: 10.1016/j.celrep.2018.05.074 |
Cell Reports 23/12 | 2020-03-03 |
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "OLIGOMERS" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "OLIGOMERS" are provided by the European Opendata Portal: CORDIS opendata.